Strategy & Games
Platformized Drug Discovery: Asset Ownership to Capability Integration
Biopharmaceutical R&D shifts from vertically integrated models (in-house labs → clinical trials → commercialization) to modular collaboration using asset-light platforms and external expert networks. Competitive advantage no longer derives from asset ownership, but from the speed and precision of integrating innovation capabilities across different nodes.
Read the daily articles behind this idea on the Chinese edition.